APO 010 companion diagnostic - Oncology VentureAlternative Names: APO010 DRP™
Latest Information Update: 11 Nov 2016
At a glance
- Originator Oncology Venture
- Developer Medical Prognosis Institute; Oncology Venture
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Multiple myeloma